Rituximab use and survival after diffuse large B-cell or follicular lymphoma: a population-based study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rituximab use and survival after diffuse large B-cell or follicular lymphoma: a population-based study

Published:2012-09-28 Issue:4 Volume:54 Page:743-751
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Keegan Theresa H. M.,Moy Lisa M.,Foran James M.,Alizadeh Ash A.,Chang Ellen T.,Shema Sarah J.,Schupp Clayton W.,Clarke Christina A.,Glaser Sally L.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2012.727415

Reference47 articles.

1. Improved survival for non-Hodgkin lymphoma patients in New South Wales, Australia

2. Improvements in Survival After Follicular Lymphoma by Race/Ethnicity and Socioeconomic Status: A Population-Based Study

3. Ongoing Improvement in Outcomes for Patients Diagnosed as Having Non-Hodgkin Lymphoma From the 1990s to the Early 21st Century

4. Impact of Socioeconomic Status & Race/Ethnicity On Survival in Diffuse Large B-Cell Lymphoma (DLBCL): A Population-Based Study.

5. Position paper on the therapeutic use of rituximab in CD20-positive diffuse large B-cell non-Hodgkin's lymphoma

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Social, political, and economic determinants of access to biologics: A scoping review of structural determinants in the clinical disparities literature;Research in Social and Administrative Pharmacy;2022-12

2. Racial disparities in the survival of patients with indolent non‐Hodgkin lymphomas in the United States;American Journal of Hematology;2021-05-03

3. Therapy and outcomes of primary central nervous system lymphoma in the United States: analysis of the National Cancer Database;Blood Advances;2016-11-30

4. The care center influences the management of lymphoma patients in a universal health care system: an observational cohort study;BMC Health Services Research;2016-08-02

5. Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort;The European Journal of Health Economics;2016-03-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3